Home Ingredients Serrapeptase (Serratiopeptidase)
Anti-InflammatoryJoint Health

Serrapeptase (Serratiopeptidase)

Serratia E15 (originally) / fermentation-derived
Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Serrapeptase is a proteolytic enzyme originally isolated from silkworm intestinal bacteria (Serratia) — now produced via fermentation. Used widely in Japan and Europe (prescription drug status in some countries) for inflammation, sinusitis, fibrocystic breast disease, post-surgical edema, and pain. Anti-inflammatory enzyme that breaks down dead tissue and inflammatory proteins without affecting healthy tissue. Strong observational/clinical practice support but rigorous Western RCT evidence limited.

Studied Dose 10-60 mg/day (typically 10-30 mg/day), standardized to 20,000-80,000 enzymatic units; taken on empty stomach
Active Compound Serrapeptase (serratiopeptidase, serralysin family metalloprotease)

Benefits

Sinusitis and Upper Respiratory Inflammation

Mazzone 1990 and others showed serrapeptase reduces sinusitis symptoms (pain, nasal secretion, obstruction, swelling) compared to placebo. Used widely in Italy, Japan, India for chronic sinusitis adjunct. Mechanism: liquefying mucus and reducing inflammatory mediators.

Supported by Trial 1, Trial 2

Post-Surgical Edema and Pain

Multiple trials (especially in oral/maxillofacial surgery, orthopedic procedures) show serrapeptase reduces post-operative swelling and pain vs placebo. Tachibana 1984 wisdom tooth surgery trial foundational. Used routinely in Japan post-operatively.

Supported by Trial 2

Fibrocystic Breast Disease

RCT showed serrapeptase (5 mg TID) reduced breast pain, swelling, and induration in fibrocystic breast disease vs placebo. Limited subsequent replication but referenced in supplement marketing.

Supported by Trial 1, Trial 2

Carpal Tunnel Syndrome (Limited Evidence)

Panagariya 1999 small trial suggested serrapeptase improves carpal tunnel symptoms. Sample size limited; not standard treatment (which includes wrist splinting, NSAIDs, corticosteroid injection, surgery for refractory cases).

Supported by Trial 2

Atherosclerosis Plaque (Theoretical)

Theoretical mechanism: serrapeptase digests atherosclerotic plaque protein components. Marketed for cardiovascular health based on this mechanism. NO human clinical evidence demonstrating cardiovascular outcomes benefit. Speculative claim.

Supported by Trial 1, Trial 2

Mechanism of action

1

Selective Proteolytic Activity

Serrapeptase digests dead/inflammatory tissue and proteins (fibrin, bradykinin, histamine, C-reactive protein) but not healthy tissue. Selective activity attributed to enzyme's substrate specificity for inflammatory mediators.

2

Bradykinin Reduction

Bradykinin is a major inflammatory mediator causing pain, edema, vasodilation. Serrapeptase degrades bradykinin — basis for anti-inflammatory and analgesic effects.

3

Mucolytic Activity

Serrapeptase breaks down mucoprotein matrix in respiratory mucus — reducing viscosity. Basis for sinusitis, bronchitis, COPD adjunctive use.

4

Enteric Coating Required

Serrapeptase is destroyed by gastric acid — requires enteric coating to deliver intact enzyme to small intestine for absorption. Quality varies dramatically by manufacturer; non-enteric-coated products may be ineffective.

Clinical trials

1
Serrapeptase for Chronic Sinusitis — Mazzone 1990
PubMed

Multicenter trial of serrapeptase (15 mg BID) vs placebo for chronic sinusitis in 193 patients for 7 days. (Mazzone 1990, J Int Med Res)

193 chronic sinusitis patients.

Serrapeptase significantly reduced sinusitis symptom scores (pain, nasal secretion, obstruction, swelling) vs placebo. Foundational European trial supporting clinical use in sinusitis.

2
Serrapeptase for Post-Surgical Edema — Tachibana 1984
PubMed

RCT of serrapeptase vs placebo for post-operative swelling after wisdom tooth surgery.

Wisdom tooth extraction patients.

Serrapeptase significantly reduced post-operative edema and pain vs placebo. Foundational trial supporting routine post-surgical use in Japan and Europe.

Side effects and drug interactions

Common Potential side effects

GI distress (nausea, abdominal pain, diarrhea).
Bleeding risk — proteolytic activity may modestly affect coagulation; pre-surgery discontinuation prudent.
Skin reactions, allergic reactions rare.
Pneumonitis (RARE but documented) — interstitial pneumonia case reports in Japanese literature; serious adverse event.
Coughing up blood (rare).
Liver enzyme elevation (rare).
Post-marketing pharmacovigilance in Japan led to RESTRICTED USE — Japanese MHLW revoked some indications based on lack of efficacy in rigorous trials.

Important Drug interactions

Anticoagulants (warfarin, DOACs) — theoretical bleeding risk; monitor.
Antiplatelet drugs (aspirin, clopidogrel) — additive bleeding risk.
NSAIDs — additive bleeding risk and additive anti-inflammatory effects.
Antibiotics — serrapeptase historically promoted to enhance antibiotic penetration into infected tissue; clinical relevance limited.
Other proteolytic enzyme supplements (bromelain, papain, nattokinase) — additive effects; unclear clinical relevance.

More Anti-Inflammatory Ingredients

Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…
Anti-Inflammatory
Meriva® (Curcumin Phytosome — Indena)
Meriva® is a CURCUMIN PHYTOSOME® formulation developed by Indena (Italy) — using Indena's…
Cognitive
Longvida® Optimized Curcumin (Verdure Sciences)
Longvida® is a PATENTED CURCUMIN EXTRACT developed by Verdure Sciences using SLCP™ (Solid…

Explore Other Ingredients

Antioxidant
Curcumin/Turmeric
Curcumin, the primary bioactive compound in turmeric (Curcuma longa), is commonly suppleme…
Muscle & Recovery
Bromelain
Bromelain is a proteolytic enzyme complex extracted from pineapple stem, widely used as a…
Sleep Health
Serezin™
Serezin™ is PLT Health Solutions' patented blend of Boswellia serrata and ginger (Zingiber…

Frequently asked questions about Serrapeptase (Serratiopeptidase)

What is Serrapeptase (Serratiopeptidase)?

Serrapeptase is a proteolytic enzyme originally isolated from silkworm intestinal bacteria (Serratia) — now produced via fermentation.

What does Serrapeptase (Serratiopeptidase) do?

Serrapeptase digests dead/inflammatory tissue and proteins (fibrin, bradykinin, histamine, C-reactive protein) but not healthy tissue. Selective activity attributed to enzyme's substrate specificity for inflammatory mediators. In clinical research, Serrapeptase (Serratiopeptidase) has been studied for sinusitis and upper respiratory inflammation, post-surgical edema and pain, fibrocystic breast disease.

Who should take Serrapeptase (Serratiopeptidase)?

Serrapeptase (Serratiopeptidase) may be most relevant for people interested in anti-inflammatory, joint health. It has been clinically studied for sinusitis and upper respiratory inflammation, post-surgical edema and pain, fibrocystic breast disease. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does Serrapeptase (Serratiopeptidase) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take Serrapeptase (Serratiopeptidase)?

For anti-inflammatory and joint goals, Serrapeptase (Serratiopeptidase) is typically taken with meals — fat-containing food often improves absorption for fat-soluble compounds. Daily consistency matters more than precise timing for cumulative anti-inflammatory effects. Always check product labeling and follow personalized guidance from your healthcare provider.

Is Serrapeptase (Serratiopeptidase) worth taking?

Serrapeptase (Serratiopeptidase) has limited clinical evidence (Evidence Level 2/5 on NutraSmarts) — preliminary research suggests potential benefit, but more rigorous trials are needed. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. Serrapeptase (Serratiopeptidase) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of Serrapeptase (Serratiopeptidase)?

The clinically studied dose for Serrapeptase (Serratiopeptidase) is 10-60 mg/day (typically 10-30 mg/day), standardized to 20,000-80,000 enzymatic units; taken on empty stomach. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Serrapeptase (Serratiopeptidase) used for?

Serrapeptase (Serratiopeptidase) is studied for sinusitis and upper respiratory inflammation, post-surgical edema and pain, fibrocystic breast disease. Mazzone 1990 and others showed serrapeptase reduces sinusitis symptoms (pain, nasal secretion, obstruction, swelling) compared to placebo. Used widely in Italy, Japan, India for chronic sinusitis adjunct.